These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25349701)

  • 1. Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).
    Tang ER; Schreiner AM; Pua BB
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S489-501. PubMed ID: 25349701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.
    Zugazagoitia J; Enguita AB; Nuñez JA; Iglesias L; Ponce S
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S526-36. PubMed ID: 25349703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
    Rodriguez EF; Monaco SE; Dacic S
    Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.
    Sun Y; Hou L; Yang Y; Xie H; Yang Y; Li Z; Zhao H; Gao W; Su B
    Onco Targets Ther; 2016; 9():4583-91. PubMed ID: 27524912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.
    Revannasiddaiah S; Thakur P; Bhardwaj B; Susheela SP; Madabhavi I
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S502-25. PubMed ID: 25349702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
    Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
    Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issues.
    Ha SY; Roh MS
    Korean J Pathol; 2013 Aug; 47(4):316-25. PubMed ID: 24009626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management.
    Tang Y; He Z; Zhu Q; Qiao G
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S589-96. PubMed ID: 25349710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comments on International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma (2011)].
    Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):793-6. PubMed ID: 22336202
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
    Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
    J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The international multidisciplinary classification of lung adenocarcinoma from IASLC/ATS/ERS and problems in clinical practice].
    Yan L; Yi X
    Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):333-8. PubMed ID: 23866662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
    Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
    Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
    Travis WD; Brambilla E; Riely GJ
    J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
    Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
    Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification.
    Zhao S; Guo T; Li J; Uramoto H; Guan H; Deng W; Gu C
    Onco Targets Ther; 2015; 8():3143-52. PubMed ID: 26604783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.